Tag: Pfizer

Occasionally, new technologies emerge that fundamentally alter how businesses operate. But without the appropriate tools—controls, safeguards, and user experiences—the promise of new technologies can get stuck.  In the past year, many have been captivated by the potential of Generative AI to revolutionize drug discovery, precision medicine, and healthcare delivery. But what tools will turn the […]

Pfizer, one of the world’s premier biopharmaceutical companies, uses machine learning (ML) and artificial intelligence (AI) for near-real-time monitoring of mammalian cell culture bioreactors to boost batch yield and reduce the risk of contamination. Using Amazon Web Services (AWS), the company developed Manufacturing Intelligence Edge (MI Edge), a platform that uses AI and ML for […]

Background Traditional assessments of disease progression and intervention efficacy used in clinical trials are often limited. These assessments normally consist of clinical outcome assessments (COAs) and patient reported outcomes (PROs). COAs are physician-derived, often requiring patients to travel to a clinical site. They are typically subjective, episodic in nature, and provide limited insight into the […]